VITATOPS: A Study of VITAmins TO Prevent Stroke

Completed

Phase N/A Results

Summary of Purpose

The VITATOPS study is a multi-center, randomized, double blind, placebo-controlled secondary stroke prevention trial to determine whether the addition of vitamin supplements (B12 500 ug, B6 25 mg, Folate 2 mg) to best medical/surgical management (including modification of risk factors) will reduce the combined incidence of recurrent vascular events (stroke, myocardial infarction) and vascular death in patients...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 February 2010.

1 Nov 1998 24 Nov 2004 1 Jun 2009 1 Jun 2009 1 Feb 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors See All

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Trial Secretariat (Julia Pizzi or Michelle Tang), VITATOPS Trial Office, Stroke Unit - Research, GPO Box X2213, Perth, Western Australia, 6847 Phone +61 8 9224 7004 FAX: +61 8 9224 8424

    VITATOPS@health.wa.gov.au